276P Development and external validation of an artificial intelligence (AI)-based machine learning model (ML) for predicting pathological complete response (pCR) in hormone-receptor (HoR)-positive/HER2-negative early breast cancer (EBC) undergoing neoadjuvant chemotherapy (NCT)
Mastrantoni, L., Garufi, G., Di Monte, E., Arcuri, G., Frescura, V., Maliziola, N., Rotondi, A., Giordano, G., Carbognin, L., Fabi, A., Paris, I., Franceschini, G., Orlandi, A., Palazzo, A., Puglisi, F., Dieci, M.V., Milella, M., Scambia, G., Tortora, G., Bria, E.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
254P Development of machine learning models for the prediction of early progression (EP) to first-line (1L) cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) therapy in oestrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC)
Pannunzio, S., Mastrantoni, L., Pontolillo, L., Garufi, G., Di Monte, E., Maliziola, N., Pasqualoni, M., Palazzo, A., Orlandi, A., Tortora, G., Bria, E.
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article
138P Activity and efficacy of neoadjuvant chemotherapy (NACT) in luminal-HER2-negative early breast cancer (EBC) according to HER2 score (low vs score 0): A retrospective study
Garufi, G., Carbognin, L., Mastrantoni, L., Maliziola, N., Di Monte, E., Arcuri, G., Frescura, V., Rotondi, A., Fabi, A., Paris, I., Marazzi, F., Franco, A., Mulè, A., Franceschini, G., Orlandi, A., Palazzo, A., Scambia, G., Tortora, G., Bria, E.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article